Related by context. Frequent words. (Click for all words.) 66 Kuvan R 66 refractory chronic lymphocytic 63 immunologic diseases 62 Initiates Phase II 62 Meets Primary Endpoint 62 R sorafenib tablets 62 ALN TTR 61 immuno inflammatory diseases 61 phenylketonuria PKU developed 61 post herpetic neuralgia PHN 61 Receives Orphan Drug Designation 61 TELINTRA 60 Entereg R 60 BEMA TM Fentanyl 60 Nanobody 60 acute decompensated heart 60 fibrotic diseases 60 novel antibody therapeutics 60 Myelofibrosis 60 voiding dysfunctions 60 Panzem R 60 gets USFDA nod 60 inflammatory autoimmune diseases 59 AzaSite Plus 59 rheumatoid arthritis psoriasis 59 Drug Candidate 59 liposomal formulation 59 painful diabetic neuropathy 59 nitric oxide donating 59 Completes Enrollment 59 elotuzumab 59 rheumatoid arthritis Crohn disease 59 TTR amyloidosis 59 immunological diseases 59 diabetic neuropathic pain 59 BioMarin develops 59 topical anti infective 59 Golimumab 59 myeloproliferative disorders 59 inflammatory autoimmune 58 DDP# 58 JAK inhibitor 58 dermatological diseases 58 MAP# 58 investigational compounds 58 Vaprisol 58 commercializes innovative biopharmaceuticals 58 Zoraxel 58 Avanafil 58 postherpetic neuralgia PHN 58 MKC# 58 non alcoholic steatohepatitis 58 ophthalmic diseases 58 cardiovascular metabolic 58 Onalta 58 carcinoid syndrome 58 personalized immunotherapy 58 Mipomersen 58 zileuton 58 vascular disrupting agent 58 relapsing multiple sclerosis 58 dermatological disorders 57 Hypoactive Sexual Desire Disorder 57 Lubiprostone 57 pseudobulbar affect PBA 57 multi kinase inhibitor 57 Microplasmin 57 bowel syndrome 57 Aliskiren 57 Phenoptin 57 Initiate Phase 57 Traficet EN 57 actinic keratosis 57 Daclizumab 57 opioid tolerant patients 57 Pivotal Phase III 57 CDP# 57 active ankylosing spondylitis 57 BEMA Buprenorphine 57 Factor VIIa 57 Soliris TM eculizumab 57 arterial thrombosis 56 receiving VELCADE 56 efalizumab 56 Zelrix 56 factor VIIa 56 diabetic macular edema 56 Etanercept 56 chemotherapy induced neutropenia 56 renal anemia 56 KRN# 56 proteasome inhibitor 56 fibromyalgia syndrome 56 phase IIb clinical 56 Overactive Bladder 56 Chronic Heart Failure 56 oropharyngeal candidiasis 56 ocular inflammation 56 bowel dysfunction 56 Vilazodone 56 postoperative ileus